UK Declines To Prosecute GSK Over Paxil Risk Information
This article was originally published in The Pink Sheet Daily
Executive Summary
MHRA determines law was insufficient to warrant criminal prosecution.
You may also be interested in...
Paxil Product Liability Suit Gets Second Look From Sen. Grassley
Grassley follows up on report that claims GSK hid Paxil's suicide risk.
FDA Requests Antidepressant Labeling Add Warning On Suicidality
The public health advisory and labeling change request follows an advisory committee recommendation for a stronger warning on the possible risks of the medications. The warning encourages health care providers to monitor patients closely for suicidal behavior although a link between the medications and suicide has not been established.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.